Opens in a new tab
vmblog logo 2024 wht (updated)

Cygna Labs to Acquire NCC Group's DDI business

Share: 

David Marshall | Published: January 19, 2023

Cygna Labs announced that it has entered into a definitive agreement to acquire NCC Group’s DDI business. The acquisition includes the purchase of the DDI Guard product, the portfolio of DDI customers, and NCC Group’s team of DDI experts.

The worldwide DDI market remains a resilient aspect of the broader network infrastructure industry. This is a key acquisition for Cygna Labs as it establishes its UK presence and expands its team of highly specialized DDI experts who will serve many large UK-based and global enterprise organizations. The addition of DDI Guard to its intellectual property will ensure a seamless integration for NCC Group customers while strengthening its team to help better serve its global client base.

NCC Group is a global cyber and software resilience business operating across multiple sectors, geographies, and technologies. With a significant market presence in the UK, Europe, and North America, and a growing footprint in Asia Pacific, the company works with organizations to assess, develop and manage their cyber resilience posture to enable them to take advantage of the opportunities that sustain their business growth.

Alexander Haecker, CEO, Cygna Labs Group GmbH, said: “Bringing together Cygna Labs’ innovative spirit and the power of our global footprint with the expertise of the NCC Group’s DDI team will benefit our existing and new customers. The team from NCC will become part of the N3K team, a wholly-owned subsidiary of Cygna Labs Group. We are committed to ensuring streamlined processes, agility, and the tools needed to enhance our independent full DDI-managed service offering.”

Christian Ehrenthal, CEO, Cygna Labs Corp., said, “As we continue our trajectory towards expanding our reach to the UK market, this acquisition not only brings us closer to fulfilling our mission of providing a seamless approach to security and compliance solutions but extends our market presence, a key objective for Cygna Labs. We are thrilled to expand our product portfolio and, in turn, provide our customers with the best in DDI services and support.”